Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/20/2022
Chinese Pharmacopoeia Commission Publishes the Compilation Guidelines ...
12/19/2022
Pfizer Opts In to LianBio Rights to RSV Candidate Sisunatovir in Great...
12/19/2022
NMPA Hosts BRICS Drug Regulatory Authorities Meeting via Videoconferen...
12/19/2022
Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4...
12/19/2022
GenFleet and Merck Enter into Trial Collaboration to Initiate Study In...
12/19/2022
U.S., China Advance Discussions On Pact To Accelerate Cancer Drug Tria...
12/16/2022
Laekna's Afuresertib Competes with Roche and AZ in AKT (PharmaDJ)
12/16/2022
Small Molecule Approvals for Rare Diseases in China Reach All-time Hig...
12/16/2022
Recent Executive Moves
12/16/2022
Drug R&D and Product Registration News Digest December 2022 (2)
12/15/2022
China's Drug Non-Clinical Safety Evaluation Research Institution Infor...
12/15/2022
Key Chinese Antimonopoly Regulator at SAMR under Investigation
12/15/2022
Wuxi Biologics Removed from U.S. Unverified List
12/15/2022
LG Chem Outlicenses Novel Gout Treatment to Innovent
12/15/2022
3D Medicines Bucks Trend with Strong Hong Kong IPO
12/14/2022
Pfizer and China Meheco Announce Deal to Distribute COVID-19 Drug Paxl...
12/14/2022
Chinese MedPharm Export Down and Import Up in the First Ten Months of ...
12/14/2022
NMPA Solicits Comments on the Provisions on Drug Standards
12/14/2022
Idorsia Out-licenses to Simcere Its Insomnia Drug Daridorexant in Chin...
12/14/2022
China Aims to Lead Next Bio Revolution with Investments in Advanced Bi...
12/13/2022
111 Begins Online Sales of Pfizer's Covid Drug Paxlovid
12/13/2022
Biosion Enters Research Collaboration with ImmunoGen to Create Novel A...
12/13/2022
Pfizer to Improve Supply of COVID Drug Paxlovid in China
12/13/2022
China to Roll Out Second COVID Vaccine Booster for High-risk Groups, E...
12/13/2022
CNIPA Issued Promotion Plan To Strengthen IP Protection (Mondaq)
12/13/2022
The "Unofficial" CN Orange Book User Guide For Pharmaceutical Patents ...
12/13/2022
Financing Rebounds for Chinese Drugmakers in November
12/12/2022
IQVIA: Chinese Retail Pharmacy Sales down 3.6% in MAT Q3/2022
12/12/2022
Sinohealth: Drug Sales of Chinese Retail Pharmacy Sector Up 3.8% in Fi...
12/9/2022
China Cracks Down on Drug Price Gouging amid Fears of COVID Spike: Reu...
Page:
62
/
719
Total number of articles:
21546
:
[First]
[<<]
[60]
[61]
[62]
[63]
[64]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit